skip to Main Content

CMS Medicare July 2017 Local Coverage Determination (LCD) Updates

CMS Medicare July 2017 Local Coverage Determination (LCD) Updates »

New and Updated CMS Medicare Local Coverage Determinations
Posted July 9, 2017

  • Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds
  • Bariatric Surgical Management of Morbid Obesity
  • Bendamustine hydrochloride (Treanda®, Bendeka™) revision to the Part A and Part B LCD
  • Bevacizumab (e.g., Avastin™) – Related to LCD L33394
  • Biofeedback revision to the Part A and Part B LCD
  • Biomarkers for Oncology
  • Cardiac Catheterization and Coronary Angiography
  • Cardiovascular Nuclear Medicine
  • Cataract Extraction
  • Chemotherapy and Biologicals
  • Coenzyme Q10 (CoQ10)
  • Collagenase clostridium histolyticum (Xiaflex®)
  • Collagenase clostridium histolyticum (Xiaflex®) retired Part A and Part B LCD
  • Drugs and Biologicals, Coding Article
  • Epidural — revision to the Part B LCD
  • Flow Cytometry
  • Intravenous Immune Globulin (IVIG) – Related to LCD L33394
  • Lumbar Epidural Steroid Injections (ESI)
  • MolDX – Oncotype DX ® Breast Cancer for DCIS (Genomic Health ™)
  • MolDX: APC and MUTYH Gene Testing
  • MolDX: PIK3CA Gene Tests Billing and Coding Guidelines
  • MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
  • MolDX: SULT4A1 Genetic Testing Billing and Coding Guidelines
  • MolDX: Xpresys Lung
  • MolDX-CDD: Percepta© Bronchial Genomic Classifier
  • MolDX-CDD: Prolaris™ Prostate Cancer Genomic Assay
  • Outpatient Psychiatry and Psychology Services
  • Pegfilgrastim (Neulasta) J2505
  • Positron Emission Tomography Scans Coverage
  • Psychiatric Codes
  • Removal of Benign Skin Lesions
  • Repeat X-ray or EKG Interpretations by Same or Different Physician
  • Screening and diagnostic mammography revision to the Part A and Part B LCD
  • Self-Administered Drug Exclusion List
  • Stereotactic Radiosurgery
  • Trastuzumab (Herceptin®)
  • Trastuzumab (Herceptin®) — revision to the Part A and Part B LCD
  • Vitamin D Assay Testing

CMS Medicare July 2017 Local Coverage Determination (LCD) Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top